Literature DB >> 22514236

Relationship between quantitative CT metrics and health status and BODE in chronic obstructive pulmonary disease.

Carlos H Martinez1, Ya-Hong Chen, Phillip M Westgate, Lyrica X Liu, Susan Murray, Jeffrey L Curtis, Barry J Make, Ella A Kazerooni, David A Lynch, Nathaniel Marchetti, George R Washko, Fernando J Martinez, Meilan K Han.   

Abstract

BACKGROUND: The value of quantitative CT (QCT) to identify chronic obstructive pulmonary disease (COPD) phenotypes is increasingly appreciated. The authors hypothesised that QCT-defined emphysema and airway abnormalities relate to St George's Respiratory Questionnaire (SGRQ) and Body-Mass Index, Airflow Obstruction, Dyspnea and Exercise Capacity Index (BODE).
METHODS: 1200 COPDGene subjects meeting Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria for COPD with QCT analysis were included. Total lung emphysema was measured using the density mask technique with a -950 Hounsfield unit threshold. An automated programme measured mean wall thickness (WT), wall area percentage (WA%) and 10 mm lumenal perimeter (pi10) in six segmental bronchi. Separate multivariate analyses examined the relative influence of airway measures and emphysema on SGRQ and BODE.
RESULTS: In separate models predicting SGRQ score, a 1 unit SD increase in each airway measure predicted higher SGRQ scores (for WT, 1.90 points higher, p=0.002; for WA%, 1.52 points higher, p=0.02; for pi10, 2.83 points higher p<0.001). The comparable increase in SGRQ for a 1 unit SD increase in emphysema percentage in these models was relatively weaker, significant only in the pi10 model (for emphysema percentage, 1.45 points higher, p=0.01). In separate models predicting BODE, a 1 unit SD increase in each airway measure predicted higher BODE scores (for WT, 1.07-fold increase, p<0.001; for WA%, 1.20-fold increase, p<0.001; for pi10, 1.16-fold increase, p<0.001). In these models, emphysema more strongly influenced BODE (range 1.24-1.26-fold increase, p<0.001).
CONCLUSION: Emphysema and airway disease both relate to clinically important parameters. The relative influence of airway disease is greater for SGRQ; the relative influence of emphysema is greater for BODE.

Entities:  

Mesh:

Year:  2012        PMID: 22514236      PMCID: PMC3719874          DOI: 10.1136/thoraxjnl-2011-201185

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  22 in total

1.  The St George's Respiratory Questionnaire.

Authors:  P W Jones; F H Quirk; C M Baveystock
Journal:  Respir Med       Date:  1991-09       Impact factor: 3.415

2.  Pulmonary rehabilitation and the BODE index in COPD.

Authors:  C G Cote; B R Celli
Journal:  Eur Respir J       Date:  2005-10       Impact factor: 16.671

3.  Why do patients with emphysema lose weight?

Authors:  M K Sridhar
Journal:  Lancet       Date:  1995-05-13       Impact factor: 79.321

Review 4.  Reference values for residual volume, functional residual capacity and total lung capacity. ATS Workshop on Lung Volume Measurements. Official Statement of The European Respiratory Society.

Authors:  J Stocks; P H Quanjer
Journal:  Eur Respir J       Date:  1995-03       Impact factor: 16.671

5.  Standardization of Spirometry, 1994 Update. American Thoracic Society.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  1995-09       Impact factor: 21.405

6.  Computed tomographic measurements of airway dimensions and emphysema in smokers. Correlation with lung function.

Authors:  Y Nakano; S Muro; H Sakai; T Hirai; K Chin; M Tsukino; K Nishimura; H Itoh; P D Paré; J C Hogg; M Mishima
Journal:  Am J Respir Crit Care Med       Date:  2000-09       Impact factor: 21.405

7.  The prediction of small airway dimensions using computed tomography.

Authors:  Yasutaka Nakano; Jonathan C Wong; Pim A de Jong; Lilliana Buzatu; Taishi Nagao; Harvey O Coxson; W Mark Elliott; James C Hogg; Peter D Paré
Journal:  Am J Respir Crit Care Med       Date:  2004-10-29       Impact factor: 21.405

8.  A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema.

Authors:  Alfred Fishman; Fernando Martinez; Keith Naunheim; Steven Piantadosi; Robert Wise; Andrew Ries; Gail Weinmann; Douglas E Wood
Journal:  N Engl J Med       Date:  2003-05-20       Impact factor: 91.245

9.  The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease.

Authors:  Bartolome R Celli; Claudia G Cote; Jose M Marin; Ciro Casanova; Maria Montes de Oca; Reina A Mendez; Victor Pinto Plata; Howard J Cabral
Journal:  N Engl J Med       Date:  2004-03-04       Impact factor: 91.245

Review 10.  Keynote review: phosphodiesterase-4 as a therapeutic target.

Authors:  Miles D Houslay; Peter Schafer; Kam Y J Zhang
Journal:  Drug Discov Today       Date:  2005-11-15       Impact factor: 7.851

View more
  58 in total

Review 1.  Airway imaging in disease: gimmick or useful tool?

Authors:  Peter D Paré; Taishi Nagano; Harvey O Coxson
Journal:  J Appl Physiol (1985)       Date:  2012-05-17

2.  Biomechanical CT metrics are associated with patient outcomes in COPD.

Authors:  Sandeep Bodduluri; Surya P Bhatt; Eric A Hoffman; John D Newell; Carlos H Martinez; Mark T Dransfield; Meilan K Han; Joseph M Reinhardt
Journal:  Thorax       Date:  2017-01-02       Impact factor: 9.139

3.  Variation in the percent of emphysema-like lung in a healthy, nonsmoking multiethnic sample. The MESA lung study.

Authors:  Eric A Hoffman; Firas S Ahmed; Heather Baumhauer; Mathew Budoff; J Jeffrey Carr; Richard Kronmal; S Reddy; R Graham Barr
Journal:  Ann Am Thorac Soc       Date:  2014-07

4.  Obstructive Sleep Apnea and Airway Dimensions in Chronic Obstructive Pulmonary Disease.

Authors:  Abigail L Koch; Robert H Brown; Han Woo; Alli C Brooker; Laura M Paulin; Hartmut Schneider; Alan R Schwartz; Gregory B Diette; Robert A Wise; Nadia N Hansel; Nirupama Putcha
Journal:  Ann Am Thorac Soc       Date:  2020-01

Review 5.  Physiologic Insights from the COPD Genetic Epidemiology Study.

Authors:  William W Stringer; Janos Porszasz; Surya P Bhatt; Meredith C McCormack; Barry J Make; Richard Casaburi
Journal:  Chronic Obstr Pulm Dis       Date:  2019-07-24

6.  Longitudinal airway remodeling in active and past smokers in a lung cancer screening population.

Authors:  Bertram J Jobst; Oliver Weinheimer; Torben Buschulte; Mila Trauth; Jan Tremper; Stefan Delorme; Nikolaus Becker; Erna Motsch; Marie-Luise Groß; Anke Trotter; Monika Eichinger; Hans-Ulrich Kauczor; Mark O Wielpütz
Journal:  Eur Radiol       Date:  2018-12-14       Impact factor: 5.315

Review 7.  The Role of Chest Computed Tomography in the Evaluation and Management of the Patient with Chronic Obstructive Pulmonary Disease.

Authors:  Wassim W Labaki; Carlos H Martinez; Fernando J Martinez; Craig J Galbán; Brian D Ross; George R Washko; R Graham Barr; Elizabeth A Regan; Harvey O Coxson; Eric A Hoffman; John D Newell; Douglas Curran-Everett; James C Hogg; James D Crapo; David A Lynch; Ella A Kazerooni; MeiLan K Han
Journal:  Am J Respir Crit Care Med       Date:  2017-12-01       Impact factor: 21.405

8.  A morphologic study of the airway structure abnormalities in patients with asthma by high-resolution computed tomography.

Authors:  Dan Wang; Jian Luo; Wen Du; Lan-Lan Zhang; Li-Xiu He; Chun-Tao Liu
Journal:  J Thorac Dis       Date:  2016-10       Impact factor: 2.895

9.  Accurate measurement of small airways on low-dose thoracic CT scans in smokers.

Authors:  Barbara A Lutey; Susan H Conradi; Jeffrey J Atkinson; Jie Zheng; Kenneth B Schechtman; Robert M Senior; David S Gierada
Journal:  Chest       Date:  2013-05       Impact factor: 9.410

10.  Age and Small Airway Imaging Abnormalities in Subjects with and without Airflow Obstruction in SPIROMICS.

Authors:  Carlos H Martinez; Alejandro A Diaz; Catherine Meldrum; Jeffrey L Curtis; Christopher B Cooper; Cheryl Pirozzi; Richard E Kanner; Robert Paine; Prescott G Woodruff; Eugene R Bleecker; Nadia N Hansel; R Graham Barr; Nathaniel Marchetti; Gerard J Criner; Ella A Kazerooni; Eric A Hoffman; Brian D Ross; Craig J Galban; Christine T Cigolle; Fernando J Martinez; MeiLan K Han
Journal:  Am J Respir Crit Care Med       Date:  2017-02-15       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.